Skip to main content

Table 1 Life span of the filter and pipeline by peripheral blood citrate concentration

From: Construction and validation of a prediction model for the risk of citrate accumulation in patients with hepatic insufficiency receiving continuous renal replacement therapy with citrate anticoagulation

Peripheral blood citrate concentration(mmol/L)

All patients(n = 253)

Life span of filter and pipeline (h)

Discontinued midway due to surgery or examination, n(%)

=1.5

23

60(56,69)

9(15.8

1.6–2.0

48

60(48,69)

8(14)

2.1–2.9

42

48(36,72)

11(19.3)

≥3.0

140

71(56,72)

29(50.9)